Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John S Bomalaski, M.D.
Polaris Group
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- A Ward of Oncology-287 Changhuai Rd
Bengbu, Anhui, China
- Oncology, No. 678, Furong Rd
Hefei, Anhui, China
- the First Hospital of Medical University of Anhui
Hefei, Anhui, China
- 5th Fl, Inpatient Bldg, No. 8,
Fengtai Distrcit, Beijing Municipality, China
- No. 156 North Road of West Second Ring
Gulou District, Fujian, China
- 15th Floor, in-Patient Building (east), No. 651 Dongfeng East Road
Guangzhou, Guangdong, China
- 5th Fl, Inpatient Bldg, No. 71, Heti Rd
Qingxiu Disttrict, Guangxi, China
- 3rd Floor, Medicine Building, No. 150 Haping Rd
Harbin, Heilongjiang, China
- Oncology, 185 Road Juqian Street
Changzhou, Jiangsu, China
- the Chinese People'S Liberation Army 81 Hospital
Nanjing, Jiangsu, China
- 5th Floor, Medical Building, No. 1018 Huguang Rd
Changchun, Jilin, China
- No. 193, Lianhe Rd, Shahekou Dist.
Dalian, Liaoning, China
- No. 596, Xinsi Rd., Baqiao Dist.
Xi'an, Shaanxi, China
- Floor 7, 3rd Inpatient Building No. 37, Guoxue Xiang
Chengdu, Sichuan, China
- 13th Floor, Internal Medicine Building, No. 29 Gaotanyan Main St.
Chongqing, China
- Bldg No. 5, 3rd Floor, Dongan Rd
Shanghai, China
- Istituto Tumori "giovanni Paolo Ii"
Bari, Italy
- Policlinico S. Orsola-Malpighi
Bologna, Italy
- Azienda Ospedaliera Niguarda Cà Granda
Milan, Italy
- Fondazione Centro San Raffaele del Monte Tabor
Milan, Italy
- Fondazione Irccs "ca Granda" Ospedale Maggiore Policlinico
Milan, Italy
- Policlinico Di Monza
Monza, Italy
- Istituto Nazionale Per Lo Studio E la Cura Dei Tumori
Naples, Italy
- Azienda Ospedaliera Di Padova
Padova, Italy
- Azienda Ospedaliera San Camillo Forlanini
Roma, Italy
- Instituto Nazionale Pler Le Malattie Infettive
Rome, Italy
- Asan Medical Center
Seoul, South Korea
- Korea University Anam Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul St. Mary'S Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- Cgmhcy
Chiayi City, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
- Chang Gung Medical Foundation-Kaohsiung
Kaohsiung County, Taiwan
- China Medicine University Hospital
Taichung, Taiwan
- Cmmc-Ly
Tainan, Taiwan
- Cmmc-Yk
Tainan, Taiwan
- National Cheng Kung University Hospital
Tainan, Taiwan
- Mackay Memorial Hospital-Taipei Branch
Taipei, Taiwan
- Northern Taiwan University Hospital
Taipei, Taiwan
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 31 Jul 2015
- Completion
- 31 Jul 2015
- Last update posted
- 6 Sept 2019
- Registered enrollment
- 636
- Registry id
- NCT01287585
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.